Kinavet-CA1 What You Should Know #22
Dr. Ettinger and Dr. Dressler discuss the use of Kinavet-CA1®, a conditionally FDA-approved drug for dogs, as a chemotherapeutic treatment for dog cancer.
Topics Covered:
- What is Kinavet?
- How does it differ from Palladia
- Safety Precautions
Editor's note: The Food and Drug Administration canceled the temporary approval for Kinavet CA1 in late 2015 due to lack of evidence of effectiveness. We have left this episode intact in order to be transparent about how treatments that show early promise don't always work out in the long-term. A similar drug, Palladia, is fully approved for use.
Other Links:
If you would like to ask a dog cancer related question for one of our expert veterinarians to answer on a future Q&A episode, call our Listener Line at 808-868-3200.
Dog Cancer News is a free weekly newsletter that contains useful information designed to help your dog with cancer. To sign up, please visit DogCancerNews.com
Learn more about your ad choices. Visit megaphone.fm/adchoices
Recent Podcasts & News
Email Address
Listen On
New to Dog Cancer Answers?
Here are some great episodes to start with. Or, check out episodes by topic.
